Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company to host conference call and webcast on March 23, 2023 at 12:30 p.m. GMT 8:30 a.m. EDT Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended
- Abstracts highlight pipeline programmes in precision oncology, including novel LSD1 inhibitor - Further detail on A2A programme, including novel biomarker for patient selection to be presented
15.03.2023 - Exscientia plc (Nasdaq: EXAI) today announced that four abstracts have been accepted for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held April 14-19, 2023, at the Orange County ... Seite 1
Precision designed LSD1 and MALT1 inhibitors currently progressing through IND-enabling studies Both molecules demonstrate Exscientia's ability to overcome critical design challenges and identify
Partnership will further validate Exscientia's functional drug testing platform to predict response in haematological cancers - Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with